Astrana Health, Inc.
ASTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $956 | $655 | $620 | $665 |
| % Growth | 46% | 5.5% | -6.7% | – |
| Cost of Goods Sold | $874 | $577 | $549 | $602 |
| Gross Profit | $82 | $78 | $71 | $63 |
| % Margin | 8.5% | 11.9% | 11.5% | 9.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $113 | $51 | $44 | $42 |
| SG&A Expenses | $113 | $51 | $44 | $42 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$51 | $7 | $7 | $21 |
| Operating Expenses | $62 | $58 | $51 | $62 |
| Operating Income | $19 | $20 | $21 | $1 |
| % Margin | 2% | 3.1% | 3.3% | 0.1% |
| Other Income/Exp. Net | -$14 | -$4 | -$11 | -$3 |
| Pre-Tax Income | $6 | $17 | $10 | -$2 |
| Tax Expense | $5 | $7 | $3 | $6 |
| Net Income | $0 | $9 | $7 | -$7 |
| % Margin | 0% | 1.4% | 1.1% | -1% |
| EPS | -0.33 | 0.19 | 0.14 | -0.14 |
| % Growth | -273.7% | 35.7% | 200% | – |
| EPS Diluted | -0.33 | 0.19 | 0.14 | -0.14 |
| Weighted Avg Shares Out | 49 | 49 | 48 | 48 |
| Weighted Avg Shares Out Dil | 49 | 49 | 49 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $2 | $2 | $3 |
| Interest Expense | $18 | $7 | $7 | $8 |
| Depreciation & Amortization | $16 | $7 | $7 | $8 |
| EBITDA | $39 | $31 | $24 | $14 |
| % Margin | 4.1% | 4.8% | 3.8% | 2.1% |